XML 46 R35.htm IDEA: XBRL DOCUMENT v3.3.1.900
RFS Pharma, LLC Acquisition (Details)
$ in Thousands
Dec. 31, 2014
USD ($)
Business Combinations [Abstract]  
Purchased in-process research and development $ 184,966
Net book value of tangible assets acquired (183)
Goodwill 65,195
Deferred tax liability (65,195)
Total purchase price $ 184,783